A Multicenter Survey Study Into Patient Experience With Mobile Apps
Sponsor
National University of Ireland, Galway, Ireland (Other)
Overall Status
Recruiting
CT.gov ID
NCT05130697
Collaborator
(none)
20
1
10
2
Study Details
Study Description
Brief Summary
This multicenter prospective survey study is designed to evaluate a newly developed mobile app that will support patients with malignant pleural effusion (MPE) treated with an indwelling pleural catheter (IPC). The aim is to test the mobile app with patients with MPE and get user feedback during and at the end of the study period.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
20 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
A Multicenter Survey Study Into Patient Experience With Mobile Apps
Actual Study Start Date
:
Jul 1, 2021
Anticipated Primary Completion Date
:
Apr 30, 2022
Anticipated Study Completion Date
:
Apr 30, 2022
Outcome Measures
Primary Outcome Measures
- The % positive usability rating rated via an mHealth App Usability Questionnaire (MAUQ) [2 weeks]
The % positive usability rating rated via an mHealth App Usability Questionnaire (MAUQ)
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Patients with MPE and, scheduled for an indwelling pleural catheter (IPC) procedure,
-
Age 18 or older
Exclusion Criteria:
-
Patients without an iOS smartphone or email account
-
Patients who refuse participation.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University Hospitals Galway | Galway | Ireland |
Sponsors and Collaborators
- National University of Ireland, Galway, Ireland
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Michelle Tierney,
Principal Investigator,
National University of Ireland, Galway, Ireland
ClinicalTrials.gov Identifier:
NCT05130697
Other Study ID Numbers:
- 2020.10.024
- 2020-1089
First Posted:
Nov 23, 2021
Last Update Posted:
Nov 23, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: